Loading…

Design and synthesis of novel alpha(1)(a) adrenoceptor-selective antagonists. 4. Structure-activity relationship in the dihydropyrimidine series

We have previously disclosed dihydropyridines such as 1a,b as selective alpha(1a) antagonists as a potential treatment for benign prostatic hyperplasia (BPH). The propensity of dihydropyridines toward an oxidation led us to find suitable replacements of the core unit. The accompanying papers describ...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 1999-11, Vol.42 (23), p.4804-4813
Main Authors: Wong, W C, Sun, W, Lagu, B, Tian, D, Marzabadi, M R, Zhang, F, Nagarathnam, D, Miao, S W, Wetzel, J M, Peng, J, Forray, C, Chang, R S, Chen, T B, Ransom, R, O'Malley, S, Broten, T P, Kling, P, Vyas, K P, Zhang, K, Gluchowski, C
Format: Article
Language:English
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We have previously disclosed dihydropyridines such as 1a,b as selective alpha(1a) antagonists as a potential treatment for benign prostatic hyperplasia (BPH). The propensity of dihydropyridines toward an oxidation led us to find suitable replacements of the core unit. The accompanying papers describe the structure-activity relationship (SAR) of dihydropyrimidinones 2a,b as selective alpha(1a) antagonists. We report herein the SAR of dihydropyrimidines such as 4 and highlight the similarities and differences between the dihydropyrimidine and dihydropyrimidinone series of compounds.
ISSN:0022-2623
1520-4804
DOI:10.1021/jm9902032